1652130 - Intellia Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - NTLA (1652130)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
27 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P5-3+8+10-40
S2+1+2-3+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-11-03
NTLABell GraemeEVP, CFOA - Grant$22.04+5,00013,400+60%+$110,217
2017-09-13
NTLACaribou Biosciences, Inc.10%S - Sale$0.00-1,048,8464,545,000-19%-$0
M
2017-07-07
NTLAFormela Jean FrancoisDirS - Sale$16.24-150,0003,579,788-4%-$2,435,440
M
2017-07-07
NTLAAtlas Venture Fund Ix, L.P.10%S - Sale$16.24-150,0003,579,788-4%-$2,435,440
2017-06-02
NTLADorsa CarolineDirA - Grant$12.42+5,0005,000New+$62,100
2017-06-01
NTLAKarsen Perry ADirA - Grant$11.98+5,0005,000New+$59,925
2017-06-02
NTLABell GraemeEVP, CFOA - Grant$12.37+8,4008,400New+$103,938
2017-06-01
NTLARivera Jose EEVP, GC, OpsA - Grant$12.03+8,400271,204+3%+$101,075
2017-06-01
NTLALeonard John M.EVP, R, DA - Grant$12.06+8,400533,223+2%+$101,322
2017-06-01
NTLABermingham NessanPres, CEOA - Grant$11.95+8,400795,033+1%+$100,379
M
2017-03-09
NTLAAtlas Venture Associates Ix, L.P.10%S - Sale$13.91-21,1323,729,788-1%-$293,843+1+2-3
M
2017-03-09
NTLAFormela Jean FrancoisDirS - Sale$13.91-21,1323,729,788-1%-$293,843+1+2-3
D
2016-05-11
NTLAOrbimed Advisors LLCDirP - Purchase$18.00+250,0002,662,180+10%+$4,500,000+7+13+14-38
D
2016-05-11
NTLAOrbimed Advisors LLCDirC - Converted deriv$0.002,412,1802,662,180-48%$0+7+13+14-38
D
2016-05-11
NTLATemasek Holdings (Private) Ltd10%P - Purchase$18.00+300,0001,281,054+31%+$5,400,000-1+13+13-39
D
2016-05-11
NTLATemasek Holdings (Private) Ltd10%C - Converted deriv$0.00490,5271,281,054-28%$0-1+13+13-39
D
2016-05-11
NTLAFormela Jean FrancoisDirC - Converted deriv$0.004,429,7884,429,788-50%$0-7+4+7-41
D
2016-05-11
NTLAAtlas Venture Fund Ix, L.P.10%C - Converted deriv$0.004,429,7884,429,788-50%$0-7+4+7-41
D
2016-05-11
NTLANovartis Institutes For Biomedical Research, Inc.10%P - Purchase$18.00+277,7775,573,658+5%+$4,999,986-7+4+7-41
D
2016-05-11
NTLANovartis Institutes For Biomedical Research, Inc.10%C - Converted deriv$0.005,295,8815,573,658-49%$0-7+4+7-41
D
2016-05-11
NTLAHaurwitz Rachel E.Dir, 10%C - Converted deriv$0.005,419,0405,593,846-49%$0-7+4+7-41
D
2016-05-11
NTLACaribou Therapeutics Holdco, LLC10%C - Converted deriv$0.005,419,0405,593,846-49%$0-7+4+7-41
D
2016-05-11
NTLAGordon Carl LDirP - Purchase$18.00+250,0002,662,180+10%+$4,500,000-7+4+7-41
D
2016-05-11
NTLAGordon Carl LDirC - Converted deriv$0.002,412,1802,662,180-48%$0-7+4+7-41
D
2016-05-11
NTLABermingham NessanPres, CEOC - Converted deriv$0.00437,019786,633-36%$0-7+4+7-41
D
2016-05-11
NTLABaker Bros. Advisors LPFormer 10% ownerP - Purchase$18.00+200,000976,214+26%+$3,600,000-7+4+7-41
D
2016-05-11
NTLABaker Bros. Advisors LPFormer 10% ownerC - Converted deriv$0.00862,120976,214-47%$0-7+4+7-41

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top